Cargando…
Meta-analysis of clinical adverse events after CABG vs. PCI in patients with chronic kidney disease and coronary artery disease
AIM: To investigate the efficacy and postoperative clinical adverse events of coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) for chronic kidney disease (CKD) study participants combined with coronary artery disease (CAD). METHODS: All randomized controlled trials...
Autores principales: | Luo, Cheng, wang, Qiang, Nong, Shuxiong, Chen, Yushan, Li, Longchang, Gui, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688048/ https://www.ncbi.nlm.nih.gov/pubmed/38037012 http://dx.doi.org/10.1186/s12872-023-03560-w |
Ejemplares similares
-
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry
por: Persson, Jonas, et al.
Publicado: (2023) -
PCI versus CABG in patients with complex coronary artery disease: Time for reconciliation?
por: ElGuindy, Ahmed M, et al.
Publicado: (2013) -
Long-term outcomes of PCI vs. CABG for ostial/midshaft lesions in unprotected left main coronary artery
por: Guo, Cheng-Long, et al.
Publicado: (2017) -
PCI or CABG, That is the Question!
por: Woo, Jong Shin, et al.
Publicado: (2017) -
Debate: PCI vs CABG: a moving target, but we are gaining
por: Holmes, David R
Publicado: (2001)